What is NDC 87706-866?

87706-866 is the product NDC for Zaynich, Zidebactam dihydrate 1 g/1; Cefepime hydrochloride 2 g/1 injection, powder, for solution, listed with the FDA by Wockhardt Suisse USA LLC. It has 1 package NDC, shown above in 10- and 11-digit form.

What drug is associated with this NDC?

Zaynich (Zidebactam dihydrate and cefepime hydrochloride).

What is the active ingredient?

Zidebactam dihydrate, Cefepime hydrochloride.

Wockhardt Suisse USA LLC, NDC labeler code 87706. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Zaynich?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Zaynich NDC 87706-866 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)87706-866Labeler and product segments. Claims need a package NDC.

Product NDC at billing width87706-0866Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
87706-866-01	8770608660187706086601	1 VIAL, SINGLE-DOSE in 1 CARTON (87706-866-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (87706-866-00)Marketed from May 29, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Zaynich
Generic name (nonproprietary): zidebactam dihydrate and cefepime hydrochloride
Active ingredients: Zidebactam dihydrate — 1 g/1Cefepime hydrochloride — 2 g/1
Dosage form: Injection, Powder, For solution
Route: Intravenous
Labeler: Wockhardt Suisse USA LLCNDC labeler code 87706
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 220787
Marketing start: May 29, 2026
Listing expires: Dec 31, 2027
Other FDA classes: Cephalosporins (Chemical structure)
Identifiers: Product ID 87706-866_5381b2e7-e719-2af8-e063-6294a90a2732SPL ID 5381b2e7-e719-2af8-e063-6294a90a2732SPL set ID c84e652e-5e76-4568-8812-bd5fa34803b6RxCUI 2744819, 2744824UNII TE54T8WC4T, I8X1O0607PUPC 0387706866001
Pharmacologic class: Cephalosporin Antibacterial

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N487706086601 followed by a unit qualifier and the quantity

Package 87706-0866-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jun 5, 2026.

Indications (excerpt from the label)

ZAYNICH is a combination of cefepime, a cephalosporin antibacterial, and zidebactam, a beta-lactamase inhibitor and non-beta-lactam antibacterial indicated for the treatment of adult patients with complicated urinary tract infections (cUTI) including pyelonephritis caused by designated susceptible microorganisms. ( 1.1 ) Usage to Reduce Development of Drug-Resistant Bacteria To reduce the development of drug-resistant bacteria and maintain the effectiveness of ZAYNICH and other antibacterial drugs, ZAYNICH should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. ( 1.2 ) 1.1 Complicated Urinary Tract Infections, including Pyelonephriti…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 87706-866

What is NDC 87706-866?: 87706-866 is the product NDC for Zaynich, Zidebactam dihydrate 1 g/1; Cefepime hydrochloride 2 g/1 injection, powder, for solution, listed with the FDA by Wockhardt Suisse USA LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Zaynich (Zidebactam dihydrate and cefepime hydrochloride).
What is the active ingredient?: Zidebactam dihydrate, Cefepime hydrochloride.
Who is the labeler?: Wockhardt Suisse USA LLC, NDC labeler code 87706. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Zaynich?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.